Clinical Trial Update: A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses [NA]

View source ↗

Summary

This study compares a generic imiquimod 3.75% cream to the brand Zyclara 3.75% cream in adults with actinic keratoses to assess bioequivalence with clinical end…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratoses

Drugs mentioned

• Generic Imiquimod Cream 3.75% (imiquimod cream 3.75%)
• ZYCLARA (Imiquimod)

Snippet

Sponsor: Actavis Mid-Atlantic LLC | Conditions: Actinic Keratoses | NA | Status: COMPLETED